Sean Fetcho is the Co-Founder and CEO
of Verséa Health, the parent company of Verséa Discovery, creators of
mescreen™.

He leads with a bold vision: to
transform preventive care by placing cellular/mitochondrial science at the
center of personalized health optimization. Under his leadership, Verséa is
advancing a new standard in precision healthcare—making innovative, science-driven
insights more accessible and actionable for individuals seeking longer,
healthier lives. Sean fosters a culture of collaboration and forward-thinking,
positioning the company at the forefront of next-generation health solutions.

Prior to founding Verséa, Sean built
and scaled eight successful print and digital publications serving oncology,
pain management, and cardiology professionals—many of which remain in
circulation today. He was later recruited into a Continuing Medical Education
(CME) organization, where he developed new revenue streams and helped position
the company for acquisition. Within three years, Aventine (PAINWeek) was
successfully sold to a publicly traded company on the London Stock Exchange.

Earlier in his career, Sean was part of
the launch team for Red Bull USA and co-founded an innovative packaging company
focused on extending the shelf life of perishable goods while eliminating
foodborne pathogens during transit.

Sean studied Economics and Psychology
at the University of Westminster and Towson University. He has also completed
executive education at Columbia Business School, with advanced training in
Neuro-Linguistic Programming, Strategic Intuition, Management, Sales, and
Business Development.

An avid traveler, Sean has visited all
50 U.S. states and over 110 countries. In his free time, he enjoys playing the
drums, snowboarding, tennis, basketball, and spending time with family and
friends—especially his son, Zeppelin.